HB 1725 Introduced

Increasing access to biosimilar medicines.

Last action: 2026-01-12 — By resolution, reintroduced and retained in present status.

Take Action

Official Description

Increasing access to biosimilar medicines.

Bill Details

Bill Number
HB 1725
Current Status
Introduced
Sponsors
My-Linh Thai, Clyde Shavers, Lisa Parshley, Davina Duerr, Nicole Macri
Introduced
2025-01-30
Chamber
House
Current Committee
Health Care and Wellness

Bill History

  • 2025-01-30 First reading, referred to Health Care & Wellness.
  • 2025-02-12 Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
  • 2026-01-12 By resolution, reintroduced and retained in present status.

How to Make Your Voice Heard

1. Submit Written Comment

Click "Comment on This Bill" above. You have up to 5,000 characters. Comments are typically open for 24 hours before hearings.

2. Testify at Hearing

Sign up to testify remotely via TVW. Check the legislative calendar for hearing times.

3. Contact Your Legislator

Use the district finder to find your representatives and reach out directly.